Geneos Wealth Management’s TriplePoint Venture Growth BDC TPVG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-815
Closed -$6.54K – 2623
2024
Q2
$6.54K Hold
815
– – ﹤0.01% 1654
2024
Q1
$7.73K Sell
815
-950
-54% -$10.1K ﹤0.01% 1605
2023
Q4
$19.2K Hold
1,765
– – ﹤0.01% 1373
2023
Q3
$18.5K Buy
1,765
+450
+34% +$5.13K ﹤0.01% 1398
2023
Q2
$15.5K Hold
1,315
– – ﹤0.01% 1453
2023
Q1
$15.9K Hold
1,315
– – ﹤0.01% 1419
2022
Q4
$13.7K Sell
1,315
-2,855
-68% -$34.6K ﹤0.01% 1446
2022
Q3
$45K Sell
4,170
-4,287
-51% -$55.8K ﹤0.01% 1067
2022
Q2
$110K Sell
8,457
-796
-9% -$12K 0.01% 980
2022
Q1
$161K Buy
9,253
+3,412
+58% +$57.8K 0.01% 891
2021
Q4
$104K Buy
5,841
+2,943
+102% +$51.5K ﹤0.01% 1154
2021
Q3
$46K Buy
2,898
+375
+15% +$5.87K ﹤0.01% 1538
2021
Q2
$39K Buy
2,523
+59
+2% +$909 ﹤0.01% 1607
2021
Q1
$39K Buy
2,464
+640
+35% +$9.02K ﹤0.01% 1761
2020
Q4
$26K Buy
+1,824
New +$22.1K ﹤0.01% 1763

Other funds holding TPVG

Geneos Wealth Management's TPVG Position: Q3 2024 in Review

Geneos Wealth Management sold out of TriplePoint Venture Growth BDC (TPVG) in Q3 2024, closing a stake of 815 shares — an estimated $6.54K sold.

Geneos Wealth Management first reported a position in TPVG in Q4 2020 and held it in 15 quarters. The position peaked at $161K in Q1 2022. 83 funds tracked by Wall St. Rank hold TPVG as of Q3 2024.

  • Geneos Wealth Management reported no remaining TriplePoint Venture Growth BDC position as of Q3 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 815 TriplePoint Venture Growth BDC shares in Q3 2024, an estimated $6.54K.
  • Geneos Wealth Management first reported a position in TriplePoint Venture Growth BDC in Q4 2020 and held it in 15 quarters.
  • Geneos Wealth Management's TriplePoint Venture Growth BDC position peaked at $161K in Q1 2022.
  • 83 funds tracked by Wall St. Rank held TriplePoint Venture Growth BDC as of Q3 2024.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.